EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes

BACKGROUND: EGFR T790M testing is the standard of care for activating EGFR mutation (EGFRm) non-small cell lung cancer (NSCLC) progressing on 1st/2nd generation TKIs to select patients for osimertinib. Despite sensitive assays, detection of circulating tumour deoxyribonucleic acid (ctDNA) is variabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pender, Alexandra, Hughesman, Curtis, Law, Elaine, Kristanti, Amadea, McNeil, Kelly, Wong, Selina, Tucker, Tracy, Bosdet, Ian, Young, Sean, Laskin, Janessa, Karsan, Aly, Yip, Stephen, Ho, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481591/
https://www.ncbi.nlm.nih.gov/pubmed/32953487
http://dx.doi.org/10.21037/tlcr-19-581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481591/
https://www.ncbi.nlm.nih.gov/pubmed/32953487
http://dx.doi.org/10.21037/tlcr-19-581

Ejemplares similares